Platelet transfusion - The new immunology of an old therapy

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Stolla, Moritz ^a   Refaai, Majed A ^a   Heal, Joanna M ^a   Spinelli, Sherry L ^a   Garraud, Olivier ^b   Phipps, Richard P ^a   Blumberg, Neil ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^b UNIVERSITÉ DE LYON   (France)

Author keywords

Bleeding; Immune response; Platelets; Storage; Thrombosis; Transfusion; Transfusion reaction

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; BLOOD GROUP A ANTIBODY; BLOOD GROUP B ANTIBODY; CD11B ANTIGEN; CELL SURFACE RECEPTOR; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; HIGH MOBILITY GROUP B1 PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTEGRIN; INTERLEUKIN 1BETA; INTERLEUKIN 27; INTERLEUKIN 6; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; MESSENGER RNA; OX40 LIGAND; PADGEM PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHOSPHATIDYLSERINE; PROSTAGLANDIN E2; PROTEIN BCL 3; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ALLOIMMUNIZATION; ANTIBODY PRODUCTION; B LYMPHOCYTE ACTIVATION; BLEEDING; BLOOD CLOTTING; BLOOD GROUP ABO SYSTEM; BLOOD TRANSFUSION REACTION; CELL CONTACT; CELL PROLIFERATION; ENCEPHALOMYOCARDITIS VIRUS; EXTRACELLULAR TRAP; HUMAN; IMMUNOLOGY; IMMUNOMODULATION; INFLAMMATION; INFLUENZA VIRUS A H1N1; LEUKOCYTE ACTIVATION; LISTERIA MONOCYTOGENES; NONHUMAN; PLATELET MICROPARTICLE; PROTEIN EXPRESSION; REVIEW; RISK; THROMBOCYTE PRESERVATION; THROMBOCYTE TRANSFUSION; THROMBOSIS; TRANSFUSION RELATED ACUTE LUNG INJURY;

EID: 84926670476     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00028     Document Type: Review

References (131)

1. Semple JW, Italiano JE Jr, Freedman J. Platelets and the immune continuum. Nat Rev Immunol (2011) 11(4):264-74. doi:10.1038/nri2956
2. Vieira-de-Abreu A, Campbell RA, Weyrich AS, Zimmerman GA. Platelets: versatile effector cells in hemostasis, inflammation, and the immune continuum. Semin Immunopathol (2012) 34(1):5-30. doi:10.1007/s00281-011-0286-4
3. van de Vijver E, De Cuyper IM, Gerrits AJ, Verhoeven AJ, Seeger K, Gutiérrez L, et al. Defects in Glanzmann thrombasthenia and LAD-III (LAD-1/v) syndrome: the role of integrin beta1 and beta3 in platelet adhesion to collagen. Blood (2012) 119(2):583-6. doi:10.1182/blood-2011-02-337188
4. Boulaftali Y, Hess PR, Getz TM, Cholka A, Stolla M, Mackman N, et al. Platelet ITAM signaling is critical for vascular integrity in inflammation. J Clin Invest (2013) 123(2):908-16. doi:10.1172/JCI65154
5. Aslam R, Speck ER, Kim M, Crow AR, Bang KW, Nestel FP, et al. Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood (2006) 107(2):637-41. doi:10.1182/blood-2005-06-2202
6. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of Toll-like receptor molecules on human platelets. Immunol Cell Biol (2005) 83(2):196-8. doi:10.1111/j.1440-1711.2005.01314.x
7. Ståhl AL, Svensson M, Mörgelin M, Svanborg C, Tarr PI, Mooney JC, et al. Lipopolysaccharide from enterohemorrhagic Escherichia coli binds to platelets through TLR4 and CD62 and is detected on circulating platelets in patients with hemolytic uremic syndrome. Blood (2006) 108(1):167-76. doi:10.1182/blood-2005-08-3219
8. Garraud O, Berthet J, Hamzeh-Cognasse H, Cognasse F. Pathogen sensing, subsequent signalling, and signalosome in human platelets. Thromb Res (2011) 127(4):283-6. doi:10.1016/j.thromres.2010.10.015
9. Berthet J, Damien P, Hamzeh-Cognasse H, Arthaud CA, Eyraud MA, Zéni F, et al. Human platelets can discriminate between various bacterial LPS isoforms via TLR4 signaling and differential cytokine secretion. Clin Immunol (2012) 145(3):189-200. doi:10.1016/j.clim.2012.09.004
10. Koupenova M, Vitseva O, MacKay CR, Beaulieu LM, Benjamin EJ, Mick E, et al. Platelet-TLR7 mediates host survival and platelet count during viral infection in the absence of platelet-dependent thrombosis. Blood (2014) 124(5):791-802. doi:10.1182/blood-2013-11-536003
11. Boilard E, Paré G, Rousseau M, Cloutier N, Dubuc I, Lévesque T, et al. Influenza virus H1N1 activates platelets through FcgammaRIIA signaling and thrombin generation. Blood (2014) 123(18):2854-63. doi:10.1182/blood-2013-07-515536
12. Rouhiainen A, Imai S, Rauvala H, Parkkinen J. Occurrence of amphoterin (HMG1) as an endogenous protein of human platelets that is exported to the cell surface upon platelet activation. Thromb Haemost (2000) 84(6):1087-94. Available from: http://th.schattauer.de/en/contents/archive/issue/892/manuscript/2627/show.html
13. Bianchi ME. HMGB1 loves company. J Leukoc Biol (2009) 86(3):573-6. doi:10.1189/jlb.1008585
14. Tian J, Avalos AM, Mao SY, Chen B, Senthil K, Wu H, et al. Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol (2007) 8(5):487-96. doi:10.1038/ni1457
15. Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): nuclear weapon in the immune arsenal. Nat Rev Immunol (2005) 5(4):331-42. doi:10.1038/nri1594
16. Orlova VV, Choi EY, Xie C, Chavakis E, Bierhaus A, Ihanus E, et al. A novel pathway of HMGB1-mediated inflammatory cell recruitment that requires Mac-1-integrin. EMBO J (2007) 26(4):1129-39. doi:10.1038/sj.emboj.7601552
17. Akbiyik F, Ray DM, Gettings KF, Blumberg N, Francis CW, Phipps RP. Human bone marrow megakaryocytes and platelets express PPARgamma, and PPARgamma agonists blunt platelet release of CD40 ligand and thromboxanes. Blood (2004) 104(5):1361-8. doi:10.1182/blood-2004-03-0926
18. Gambaryan S, Kobsar A, Rukoyatkina N, Herterich S, Geiger J, Smolenski A, et al. Thrombin and collagen induce a feedback inhibitory signaling pathway in platelets involving dissociation of the catalytic subunit of protein kinase A from an NFkappaB-IkappaB complex. J Biol Chem (2010) 285(24):18352-63. doi:10.1074/jbc.M109.077602
19. Liu F, Morris S, Epps J, Carroll R. Demonstration of an activation regulated NF-kappaB/I-kappaBalpha complex in human platelets. Thromb Res (2002) 106(4-5):199-203. doi:10.1016/S0049-3848(02)00130-5
20. Spinelli SL, Casey AE, Pollock SJ, Gertz JM, McMillan DH, Narasipura SD, et al. Platelets and megakaryocytes contain functional nuclear factor-kappaB. Arterioscler Thromb Vasc Biol (2010) 30(3):591-8. doi:10.1161/ATVBAHA.109.197343
21. Spinelli SL, Maggirwar SB, Blumberg N, Phipps RP. Nuclear emancipation: a platelet tour de force. Sci Signal (2010) 3(144):e37. doi:10.1126/scisignal.3144pe37
22. Weyrich AS, Dixon DA, Pabla R, Elstad MR, McIntyre TM, Prescott SM, et al. Signal-dependent translation of a regulatory protein, Bcl-3, in activated human platelets. Proc Natl Acad Sci U S A (1998) 95(10):5556-61. doi:10.1073/pnas.95.10.5556
23. Denis MM, Tolley ND, Bunting M, Schwertz H, Jiang H, Lindemann S, et al. Escaping the nuclear confines: signal-dependent pre-mRNA splicing in anucleate platelets. Cell (2005) 122(3):379-91. doi:10.1016/j.cell.2005.06.015
24. Lindemann S, Tolley ND, Dixon DA, McIntyre TM, Prescott SM, Zimmerman GA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol (2001) 154(3):485-90. doi:10.1083/jcb.200105058
25. Li N. Platelet-lymphocyte cross-talk. J Leukoc Biol (2008) 83(5):1069-78. doi:10.1189/jlb.0907615
26. van Gils JM, Zwaginga JJ, Hordijk PL. Molecular and functional interactions among monocytes, platelets, and endothelial cells and their relevance for cardiovascular diseases. J Leukoc Biol (2009) 85(2):195-204. doi:10.1189/jlb.0708400
27. Zarbock A, Polanowska-Grabowska RK, Ley K. Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev (2007) 21(2):99-111. doi:10.1016/j.blre.2006.06.001
28. Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, et al. Platelet functions beyond hemostasis. J Thromb Haemost (2009) 7(11):1759-66. doi:10.1111/j.1538-7836.2009.03586.x
29. Leppanen A, White SP, Helin J, McEver RP, Cummings RD. Binding of glycosulfopeptides to P-selectin requires stereospecific contributions of individual tyrosine sulfate and sugar residues. J Biol Chem (2000) 275(50):39569-78. doi:10.1074/jbc.M005005200
30. McEver RP, Cummings RD. Perspectives series: cell adhesion in vascular biology. Role of PSGL-1 binding to selectins in leukocyte recruitment. J Clin Invest (1997) 100(3):485-91. doi:10.1172/JCI119556
31. Wang HB, Wang JT, Zhang L, Geng ZH, Xu WL, Xu T, et al. P-selectin primes leukocyte integrin activation during inflammation. Nat Immunol (2007) 8(8):882-92. doi:10.1038/nature05671
32. Evangelista V, Pamuklar Z, Piccoli A, Manarini S, Dell'elba G, Pecce R, et al. Src family kinases mediate neutrophil adhesion to adherent platelets. Blood (2007) 109(6):2461-9. doi:10.1182/blood-2006-06-029082
33. Diacovo TG, Roth SJ, Buccola JM, Bainton DF, Springer TA. Neutrophil rolling, arrest, and transmigration across activated, surface-adherent platelets via sequential action of P-selectin and the beta 2-integrin CD11b/CD18. Blood (1996) 88(1):146-57.
34. Ghasemzadeh M, Hosseini E. Platelet-leukocyte crosstalk: linking proinflammatory responses to procoagulant state. Thromb Res (2013) 131(3):191-7. doi:10.1016/j.thromres.2012.11.028
35. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood (1991) 78(7):1760-9.
36. Schulz C, Schäfer A, Stolla M, Kerstan S, Lorenz M, von Brühl ML, et al. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets. Circulation (2007) 116(7):764-73. doi:10.1161/CIRCULATIONAHA.107.695189
37. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Chavarin P, Cogné M, Richard Y, et al. Human platelets can activate peripheral blood B cells and increase production of immunoglobulins. Exp Hematol (2007) 35(9):1376-87. doi:10.1016/j.exphem.2007.05.021
38. Henn V, Slupsky JR, Gräfe M, Anagnostopoulos I, Förster R, Müller-Berghaus G, et al. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature (1998) 391(6667):591-4. doi:10.1038/35393
39. Khan SY, Kelher MR, Heal JM, Blumberg N, Boshkov LK, Phipps R, et al. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury. Blood (2006) 108(7):2455-62. doi:10.1182/blood-2006-04-017251
40. Boulaftali Y, Hess PR, Kahn ML, Bergmeier W. Platelet immunoreceptor tyrosine-based activation motif (ITAM) signaling and vascular integrity. Circ Res (2014) 114(7):1174-84. doi:10.1161/CIRCRESAHA.114.301611
41. Goerge T, Ho-Tin-Noe B, Carbo C, Benarafa C, Remold-O'Donnell E, Zhao BQ, et al. Inflammation induces hemorrhage in thrombocytopenia. Blood (2008) 111(10):4958-64. doi:10.1182/blood-2007-11-123620
42. Ho-Tin-Noe B, Demers M, Wagner DD. How platelets safeguard vascular integrity. J Thromb Haemost (2011) 9(Suppl 1):56-65. doi:10.1111/j.1538-7836.2011.04317.x
43. Ho-Tin-Noe B, Carbo C, Demers M, Cifuni SM, Goerge T, Wagner DD. Innate immune cells induce hemorrhage in tumors during thrombocytopenia. Am J Pathol (2009) 175(4):1699-708. doi:10.2353/ajpath.2009.090460
44. Ho-Tin-Noe B, Goerge T, Wagner DD. Platelets: guardians of tumor vasculature. Cancer Res (2009) 69(14):5623-6. doi:10.1158/0008-5472.CAN-09-1370
45. Cloutier N, Pare A, Farndale RW, Schumacher HR, Nigrovic PA, Lacroix S, et al. Platelets can enhance vascular permeability. Blood (2012) 120(6):1334-43. doi:10.1182/blood-2012-02-413047
46. Hottz ED, Lopes JF, Freitas C, Valls-de-Souza R, Oliveira MF, Bozza MT, et al. Platelets mediate increased endothelium permeability in dengue through NLRP3-inflammasome activation. Blood (2013) 122(20):3405-14. doi:10.1182/blood-2013-05-504449
47. Zapata JC, Cox D, Salvato MS. The role of platelets in the pathogenesis of viral hemorrhagic fevers. PLoS Negl Trop Dis (2014) 8(6):e2858. doi:10.1371/journal.pntd.0002858
48. Risitano A, Beaulieu LM, Vitseva O, Freedman JE. Platelets and platelet-like particles mediate intercellular RNA transfer. Blood (2012) 119(26):6288-95. doi:10.1182/blood-2011-12-396440
49. Massberg S, Grahl L, von Bruehl ML, Manukyan D, Pfeiler S, Goosmann C, et al. Reciprocal coupling of coagulation and innate immunity via neutrophil serine proteases. Nat Med (2010) 16(8):887-96. doi:10.1038/nm.2184
50. Ruf W, Ruggeri ZM. Neutrophils release brakes of coagulation. Nat Med (2010) 16(8):851-2. doi:10.1038/nm0810-851
51. Kraemer BF, Campbell RA, Schwertz H, Cody MJ, Franks Z, Tolley ND, et al. Novel anti-bacterial activities of beta-defensin 1 in human platelets: suppression of pathogen growth and signaling of neutrophil extracellular trap formation. PLoS Pathog (2011) 7(11):e1002355. doi:10.1371/journal.ppat.1002355
52. Clark SR, Ma AC, Tavener SA, McDonald B, Goodarzi Z, Kelly MM, et al. Platelet TLR4 activates neutrophil extracellular traps to ensnare bacteria in septic blood. Nat Med (2007) 13(4):463-9. doi:10.1038/nm1565
53. Caudrillier A, Kessenbrock K, Gilliss BM, Nguyen JX, Marques MB, Monestier M, et al. Platelets induce neutrophil extracellular traps in transfusion-related acute lung injury. J Clin Invest (2012) 122(7):2661-71. doi:10.1172/JCI61303
54. Looney MR, Nguyen JX, Hu Y, Van Ziffle JA, Lowell CA, Matthay MA. Platelet depletion and aspirin treatment protect mice in a two-event model of transfusion-related acute lung injury. J Clin Invest (2009) 119(11):3450-61. doi:10.1172/JCI38432
55. Boudreau LH, Duchez AC, Cloutier N, Soulet D, Martin N, Bollinger J, et al. Platelets release mitochondria serving as substrate for bactericidal group IIA secreted phospholipase A2 to promote inflammation. Blood (2014) 124(14):2173-83. doi:10.1182/blood-2014-05-573543
56. Cognasse F, Hamzeh-Cognasse H, Lafarge S, Acquart S, Chavarin P, Courbil R, et al. Donor platelets stored for at least 3 days can elicit activation marker expression by the recipient's blood mononuclear cells: an in vitro study. Transfusion (2009) 49(1):91-8. doi:10.1111/j.1537-2995.2008.01931.x
57. Kostelijk EH, Fijnheer R, Nieuwenhuis HK, Gouwerok CW, de Korte D. Soluble P-selectin as parameter for platelet activation during storage. Thromb Haemost (1996) 76(6):1086-9.
58. Kaufman J, Spinelli SL, Schultz E, Blumberg N, Phipps RP. Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost (2007) 5(4):788-96. doi:10.1111/j.1538-7836.2007.02412.x
59. Hamzeh-Cognasse H, Cognasse F, Palle S, Chavarin P, Olivier T, Delézay O, et al. Direct contact of platelets and their released products exert different effects on human dendritic cell maturation. BMC Immunol (2008) 9:54. doi:10.1186/1471-2172-9-54
60. Elzey BD, Schmidt NW, Crist SA, Kresowik TP, Harty JT, Nieswandt B, et al. Platelet-derived CD154 enables T-cell priming and protection against Listeria monocytogenes challenge. Blood (2008) 111(7):3684-91. doi:10.1182/blood-2007-05-091728
61. André P, Prasad KS, Denis CV, He M, Papalia JM, Hynes RO, et al. CD40L stabilizes arterial thrombi by a beta3 integrin-dependent mechanism. Nat Med (2002) 8(3):247-52. doi:10.1038/nm0302-247
62. Snyder EL, Hezzey A, Katz AJ, Bock J. Occurrence of the release reaction during preparation and storage of platelet concentrates. Vox Sang (1981) 41(3):172-7. doi:10.1111/j.1423-0410.1981.tb01032.x
63. Berger G, Hartwell DW, Wagner DD. P-Selectin and platelet clearance. Blood (1998) 92(11):4446-52.
64. Michelson AD, Barnard MR, Hechtman HB, MacGregor H, Connolly RJ, Loscalzo J, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 93(21):11877-82. doi:10.1073/pnas.93.21.11877
65. Krishnamurti C, Maglasang P, Rothwell SW. Reduction of blood loss by infusion of human platelets in a rabbit kidney injury model. Transfusion (1999) 39(9):967-74. doi:10.1046/j.1537-2995.1999.39090967.x
66. Rank A, Nieuwland R, Liebhardt S, Iberer M, Grützner S, Toth B, et al. Apheresis platelet concentrates contain platelet-derived and endothelial cell-derived microparticles. Vox Sang (2011) 100(2):179-86. doi:10.1111/j.1423-0410.2010.01385.x
67. Sloand EM, Yu M, Klein HG. Comparison of random-donor platelet concentrates prepared from whole blood units and platelets prepared from single-donor apheresis collections. Transfusion (1996) 36(11-12):955-9. doi:10.1046/j.1537-2995.1996.36111297091737.x
68. Boilard E, Nigrovic PA, Larabee K, Watts GF, Coblyn JS, Weinblatt ME, et al. Platelets amplify inflammation in arthritis via collagen-dependent microparticle production. Science (2010) 327(5965):580-3. doi:10.1126/science.1181928
69. Huo Y, Schober A, Forlow SB, Smith DF, Hyman MC, Jung S, et al. Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med (2003) 9(1):61-7. doi:10.1038/nm810
70. Massberg S, Brand K, Grüner S, Page S, Müller E, Müller I, et al. A critical role of platelet adhesion in the initiation of atherosclerotic lesion formation. J Exp Med (2002) 196(7):887-96. doi:10.1084/jem.20012044
71. Nomura S, Suzuki M, Katsura K, Xie GL, Miyazaki Y, Miyake T, et al. Platelet-derived microparticles may influence the development of atherosclerosis in diabetes mellitus. Atherosclerosis (1995) 116(2):235-40. doi:10.1016/0021-9150(95)05551-7
72. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C. Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 25(7):1512-8. doi:10.1161/01.ATV.0000170133.43608.37
73. Brown GT, McIntyre TM. Lipopolysaccharide signaling without a nucleus: kinase cascades stimulate platelet shedding of proinflammatory IL-1beta-rich microparticles. J Immunol (2011) 186(9):5489-96. doi:10.4049/jimmunol.1001623
74. Ray DM, Spinelli SL, Pollock SJ, Murant TI, O'Brien JJ, Blumberg N, et al. Peroxisome proliferator-activated receptor gamma and retinoid X receptor transcription factors are released from activated human platelets and shed in microparticles. Thromb Haemost (2008) 99(1):86-95. doi:10.1160/TH07-05-0328
75. Elzey BD, Ratliff TL, Sowa JM, Crist SA. Platelet CD40L at the interface of adaptive immunity. Thromb Res (2011) 127(3):180-3. doi:10.1016/j.thromres.2010.10.011
76. Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood (2008) 111(10):5028-36. doi:10.1182/blood-2007-06-097410
77. Assinger A, Kral JB, Yaiw KC, Schrottmaier WC, Kurzejamska E, Wang Y, et al. Human cytomegalovirus-platelet interaction triggers toll-like receptor 2-dependent proinflammatory and proangiogenic responses. Arterioscler Thromb Vasc Biol (2014) 34(4):801-9. doi:10.1161/ATVBAHA.114.303287
78. Sahler J, Woeller C, Spinelli S, Blumberg N, Phipps R. A novel method for overexpression of peroxisome proliferator-activated receptor-gamma in megakaryocyte and platelet microparticles achieves transcellular signaling. J Thromb Haemost (2012) 10(12):2563-72. doi:10.1111/jth.12017
79. Blajchman MA, Bardossy L, Carmen RA, Goldman M, Heddle NM, Singal DP. An animal model of allogeneic donor platelet refractoriness: the effect of the time of leukodepletion. Blood (1992) 79(5):1371-5.
80. Cholette JM, Henrichs KF, Alfieris GM, Powers KS, Phipps R, Spinelli SL, et al. Washing red blood cells and platelets transfused in cardiac surgery reduces postoperative inflammation and number of transfusions: results of a prospective, randomized, controlled clinical trial. Pediatr Crit Care Med (2012) 13(3):290-9. doi:10.1097/PCC.0b013e31822f173c
81. Heddle NM, Klama LN, Griffith L, Roberts R, Shukla G, Kelton JG. A prospective study to identify the risk factors associated with acute reactions to platelet and red cell transfusions. Transfusion (1993) 33(10):794-7. doi:10.1046/j.1537-2995.1993.331094054613.x
82. Phipps RP, Kaufman J, Blumberg N. Platelet derived CD154 (CD40 ligand) and febrile responses to transfusion. Lancet (2001) 357(9273):2023-4. doi:10.1016/S0140-6736(00)05108-4
83. Heddle NM, Klama L, Singer J, Richards C, Fedak P, Walker I, et al. The role of the plasma from platelet concentrates in transfusion reactions. N Engl J Med (1994) 331(10):625-8. doi:10.1056/NEJM199409083311001
84. Hamzeh-Cognasse H, Damien P, Nguyen KA, Arthaud CA, Eyraud MA, Chavarin P, et al. Immune-reactive soluble OX40 ligand, soluble CD40 ligand, and interleukin-27 are simultaneously oversecreted in platelet components associated with acute transfusion reactions. Transfusion (2014) 54(3):613-25. doi:10.1111/trf.12378
85. Hetland G, Mollnes TE, Bergh K, Hogasen K, Bergerud UE, Solheim BG. Effect of filtration and storage of platelet concentrates on the production of the chemotaxins C5a, interleukin 8, tumor necrosis factor alpha, and leukotriene B4. Transfusion (1998) 38(1):16-23. doi:10.1046/j.1537-2995.1998.38198141493.x
86. Wang RR, Triulzi DJ, Qu L. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Am J Clin Pathol (2012) 138(2):255-9. doi:10.1309/AJCP5H7EKZTGGBKZ
87. Vo TD, Cowles J, Heal JM, Blumberg N. Platelet washing to prevent recurrent febrile reactions to leucocyte-reduced transfusions. Transfus Med (2001) 11(1):45-7. doi:10.1046/j.1365-3148.2001.00280.x
88. Cognasse F, Boussoulade F, Chavarin P, Acquart S, Fabrigli P, Lamy B, et al. Release of potential immunomodulatory factors during platelet storage. Transfusion (2006) 46(7):1184-9. doi:10.1111/j.1537-2995.2006.00869.x
89. Kunz D, Luley C, Heim MU, Bock M. Transforming growth factor beta is increased in plasma of patients with hematologic malignancies after transfusion of platelet concentrates. Transfusion (1998) 38(2):156-9. doi:10.1046/j.1537-2995.1998.38298193097.x
90. Kanter J, Khan SY, Kelher M, Gore L, Silliman CC. Oncogenic and angiogenic growth factors accumulate during routine storage of apheresis platelet concentrates. Clin Cancer Res (2008) 14(12):3942-7. doi:10.1158/1078-0432.CCR-07-4824
91. Mohle R, Green D, Moore MA, Nachman RL, Rafii S. Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets. Proc Natl Acad Sci U S A (1997) 94(2):663-8. doi:10.1073/pnas.94.2.663
92. Fong KP, Barry C, Tran AN, Traxler EA, Wannemacher KM, Tang HY, et al. Deciphering the human platelet sheddome. Blood (2011) 117(1):e15-26. doi:10.1182/blood-2010-05-283838
93. Springer DL, Miller JH, Spinelli SL, Pasa-Tolic L, Purvine SO, Daly DS, et al. Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 8(5):2261-72. doi:10.1021/pr800885j
94. Yazer MH, Triulzi DJ, Shaz B, Kraus T, Zimring JC. Does a febrile reaction to platelets predispose recipients to red blood cell alloimmunization? Transfusion (2009) 49(6):1070-5. doi:10.1111/j.1537-2995.2009.02116.x
95. Hendrickson JE, Desmarets M, Deshpande SS, Chadwick TE, Hillyer CD, Roback JD, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion (2006) 46(9):1526-36. doi:10.1111/j.1537-2995.2006.00946.x
96. Hendrickson JE, Chadwick TE, Roback JD, Hillyer CD, Zimring JC. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood (2007) 110(7):2736-43. doi:10.1182/blood-2007-03-083105
97. Heal JM, Phipps RP, Blumberg N. One big unhappy family: transfusion alloimmunization, thrombosis, and immune modulation/inflammation. Transfusion (2009) 49(6):1032-6. doi:10.1111/j.1537-2995.2009.02182.x
98. Opelz G, Terasaki PI. Poor kidney-transplant survival in recipients with frozen-blood transfusions or no transfusions. Lancet (1974) 2(7882):696-8. doi:10.1016/S0140-6736(74)93268-1
99. Burrows L, Tartter P, Aufses A. Increased recurrence rates in perioperatively transfused colorectal malignancy patients. Cancer Detect Prev (1987) 10(5-6):361-9.
100. Blumberg N, Agarwal MM, Chuang C. Relation between recurrence of cancer of the colon and blood transfusion. Br Med J (1985) 290(6474):1037-9. doi:10.1136/bmj.290.6474.1037
101. Burrows L, Tartter P. Effect of blood transfusions on colonic malignancy recurrent rate. Lancet (1982) 2(8299):662. doi:10.1016/S0140-6736(82)92764-7
102. Tartter PI, Quintero S, Barron DM. Perioperative blood transfusion associated with infectious complications after colorectal cancer operations. Am J Surg (1986) 152(5):479-82. doi:10.1016/0002-9610(86)90207-2
103. Babcock GF, Alexander JW. The effects of blood transfusion on cytokine production by TH1 and TH2 lymphocytes in the mouse. Transplantation (1996) 61(3):465-8. doi:10.1097/00007890-199602150-00026
104. Kirkley SA, Cowles J, Pellegrini VD Jr, Harris CM, Boyd AD, Blumberg N. Cytokine secretion after allogeneic or autologous blood transfusion. Lancet (1995) 345(8948):527. doi:10.1016/S0140-6736(95)90627-4
105. Blumberg N, Phipps RP, Kaufman J, Heal JM. The causes and treatment of reactions to platelet transfusions. Transfusion (2003) 43(2):291-2. doi:10.1046/j.1537-2995.2003.t01-2-00362.x
106. Blumberg N, Gettings KF, Turner C, Heal JM, Phipps RP. An association of soluble CD40 ligand (CD154) with adverse reactions to platelet transfusions. Transfusion (2006) 46(10):1813-21. doi:10.1111/j.1537-2995.2006.00979.x
107. Blumberg N, Heal JM, Liesveld JL, Phillips GL, Rowe JM. Platelet transfusion and survival in adults with acute leukemia. Leukemia (2008) 22(3):631-5. doi:10.1038/sj.leu.2404920
108. Blumberg N, Heal JM, Rowe JM. A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440]. BMC Blood Disord (2004) 4(1):6. doi:10.1186/1471-2326-4-6
109. Thomas GM, Carbo C, Curtis BR, Martinod K, Mazo IB, Schatzberg D, et al. Extracellular DNA traps are associated with the pathogenesis of TRALI in humans and mice. Blood (2012) 119(26):6335-43. doi:10.1182/blood-2012-01-405183
110. Gurevitch J, Nelken D. ABO groups in blood platelets. Nature (1954) 173(4399):356. doi:10.1038/173356a0
111. Santoso S, Kiefel V, Mueller-Eckhardt C. Blood group A and B determinants are expressed on platelet glycoproteins IIa, IIIa, and Ib. Thromb Haemost (1991) 65(2):196-201.
112. Ogasawara K, Ueki J, Takenaka M, Furihata K. Study on the expression of ABH antigens on platelets. Blood (1993) 82(3):993-9.
113. Aster RH. Effect of anticoagulant and ABO incompatibility on recovery of transfused human platelets. Blood (1965) 26(6):732-43.
114. Pavenski K, Warkentin TE, Shen H, Liu Y, Heddle NM. Posttransfusion platelet count increments after ABO-compatible versus ABO-incompatible platelet transfusions in noncancer patients: an observational study. Transfusion (2010) 50(7):1552-60. doi:10.1111/j.1537-2995.2010.02602.x
115. Slichter SJ, Davis K, Enright H, Braine H, Gernsheimer T, Kao KJ, et al. Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients. Blood (2005) 105(10):4106-14. doi:10.1182/blood-2003-08-2724
116. Heal JM, Rowe JM, McMican A, Masel D, Finke C, Blumberg N. The role of ABO matching in platelet transfusion. Eur J Haematol (1993) 50(2):110-7. doi:10.1111/j.1600-0609.1993.tb00150.x
117. Refaai MA, Carter J, Henrichs KF, Davidson DC, Pollock SJ, Casey AE, et al. Alterations of platelet function and clot formation kinetics after in vitro exposure to anti-A and-B. Transfusion (2013) 53(2):382-93. doi:10.1111/j.1537-2995.2012.03718.x
118. Heal JM, Masel D, Blumberg N. Interaction of platelet fc and complement receptors with circulating immune complexes involving the AB0 system. Vox Sang (1996) 71(4):205-11. doi:10.1046/j.1423-0410.1996.7140205.x
119. Blumberg N, Heal JM, Hicks GL Jr, Risher WH. Association of ABO-mismatched platelet transfusions with morbidity and mortality in cardiac surgery. Transfusion (2001) 41(6):790-3. doi:10.1046/j.1537-2995.2001.41060790.x
120. Refaai MA, Fialkow LB, Heal JM, Henrichs KF, Spinelli SL, Phipps RP, et al. An association of ABO non-identical platelet and cryoprecipitate transfusions with altered red cell transfusion needs in surgical patients. Vox Sang (2011) 101(1):55-60. doi:10.1111/j.1423-0410.2010.01464.x
121. Henrichs KF, Howk N, Masel DS, Thayer M, Refaai MA, Kirkley SA, et al. Providing ABO-identical platelets and cryoprecipitate to (almost) all patients: approach, logistics, and associated decreases in transfusion reaction and red blood cell alloimmunization incidence. Transfusion (2012) 52(3):635-40. doi:10.1111/j.1537-2995.2011.03329.x
122. Levin MD, de Veld JC, van der Holt B, van 't Veer MB. Immune and nonimmune causes of low recovery from leukodepleted platelet transfusions: a prospective study. Ann Hematol (2003) 82(6):357-62. doi:10.1007/s00277-003-0648-7
123. Seftel MD, Growe GH, Petraszko T, Benny WB, Le A, Lee CY, et al. Universal prestorage leukoreduction in Canada decreases platelet alloimmunization and refractoriness. Blood (2004) 103(1):333-9. doi:10.1182/blood-2003-03-0940
124. Petz LD, Garratty G, Calhoun L, Clark BD, Terasaki PI, Gresens C, et al. Selecting donors of platelets for refractory patients on the basis of HLA antibody specificity. Transfusion (2000) 40(12):1446-56. doi:10.1046/j.1537-2995.2000.40121446.x
125. Khorana AA, Francis CW, Blumberg N, Culakova E, Refaai MA, Lyman GH. Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med (2008) 168(21):2377-81. doi:10.1001/archinte.168.21.2377
126. Tan TW, Farber A, Hamburg NM, Eberhardt RT, Rybin D, Doros G, et al. Blood transfusion for lower extremity bypass is associated with increased wound infection and graft thrombosis. J Am Coll Surg (2013) 216(5):1005-14.e2. doi:10.1016/j.jamcollsurg.2013.01.006
127. Tollefson MK, Karnes RJ, Rangel L, Carlson R, Boorjian SA. Blood type, lymphadenectomy and blood transfusion predict venous thromboembolic events following radical prostatectomy with pelvic lymphadenectomy. J Urol (2014) 191(3):646-51. doi:10.1016/j.juro.2013.10.062
128. Blumberg N, Spinelli SL, Francis CW, Taubman MB, Phipps RP. The platelet as an immune cell-CD40 ligand and transfusion immunomodulation. Immunol Res (2009) 45(2-3):251-60. doi:10.1007/s12026-009-8106-9
129. Prasad KS, Andre P, Yan Y, Phillips DR. The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease. Curr Opin Hematol (2003) 10(5):356-61. doi:10.1097/00062752-200309000-00006
130. Nomura S, Okamae F, Abe M, Hosokawa M, Yamaoka M, Ohtani T, et al. Platelets expressing P-selectin and platelet-derived microparticles in stored platelet concentrates bind to PSGL-1 on filtrated leukocytes. Clin Appl Thromb Hemost (2000) 6(4):213-21. doi:10.1177/107602960000600406
131. Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associate with fibrin during thrombosis. Blood (1996) 87(11):4651-63.